Trulieve Cannabis (TRLV) EBIT (2020 - 2026)

Trulieve Cannabis (TRLV) has reported EBIT for 7 consecutive years, with $35.7 million the latest figure, recorded in Q1 2026.

• In Q1 2026, EBIT rose 7.2% year-over-year to $35.7 million; the TTM figure through Mar 2026 stood at $145.9 million (up 71.63% YoY), while the FY2025 annual figure was $143.5 million, up 46.75% from the prior year.
• EBIT came in at $35.7 million for Q1 2026 at Trulieve Cannabis, up from $15.3 million in the prior quarter.
• The five-year high for EBIT was $52.6 million in Q2 2025, with the low at -$291.3 million in Q2 2023.
• Average EBIT over 5 years is $6.1 million, with a median of $29.2 million recorded in 2022.
• Across the five-year window, EBIT sank 802.35% in 2023 and surged 6734.63% in 2025, its largest moves.
• Year by year, EBIT stood at $5.2 million in 2022, then soared by 460.51% to $29.2 million in 2023, then plunged by 95.52% to $1.3 million in 2024, then soared by 1069.5% to $15.3 million in 2025, then soared by 133.54% to $35.7 million in 2026.
• According to Business Quant data, EBIT over the past three periods registered $35.7 million, $15.3 million, and $42.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.